Both genome segments contribute to the pathogenicity of very virulent infectious bursal disease virus

Journal of Virology

Volumn 87, Issue 5, 2013, Pages 2767-2780

  Escaffre, Olivier ^a,f   Nouën, Cyril Le ^a,c   Amelot, Michel ^b   Ambroggio, Xavier ^c   Ogden, Kristen M ^c   Guionie, Olivier ^a   Toquin, Didier ^a   Müller, Hermann ^d   Islam, Mohammed R ^e   Eterradossi, Nicolas ^a  

^a Avian and Rabbit Virology   (France)

^b Anses French Agency for Food Environmental and Occupational Health Safety   (France)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e BANGLADESH AGRICULTURAL UNIVERSITY   (Bangladesh)

^f University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN VP1; PROTEIN VP2; VALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGENICITY; ARTICLE; CHICKEN; CONTROLLED STUDY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFECTIOUS BURSAL DISEASE VIRUS; MAST CELL; MOLECULAR DYNAMICS; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BIRNAVIRIDAE INFECTIONS; CHICK EMBRYO; CHICKENS; INFECTIOUS BURSAL DISEASE VIRUS; MOLECULAR DYNAMICS SIMULATION; POULTRY DISEASES; SEQUENCE ANALYSIS, RNA; SPLEEN; THYMUS GLAND; VIRAL STRUCTURAL PROTEINS;

EID: 84874712939     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02360-12     Document Type: Article

References (72)

1. Lasher HN, Shane SM. 1994. Infectious bursal disease. World's Poult. Sci. J. 50:133-166.
2. van den Berg TP. 2000. Acute infectious bursal disease in poultry: a review. Avian Pathol. 29:175-194.
3. Rauw F, Lambrecht B, van den Berg T. 2007. Pivotal role of ChIFNα in the pathogenesis and immunosuppression of infectious bursal disease. Avian Pathol. 36:367-374.
4. Wang D, Liu Y, She R, Xu J, Liu L, Xiong J, Yang Y, Sun Q, Peng K. 2009. Reduced mucosal injury of SPF chickens by mast cell stabilization after infection with very virulent infectious bursal disease virus. Vet. Immunol. Immunopathol. 131:229 -237.
5. Hassan MK, Al-Natour MQ, Ward LA, Saif YM. 1996. Pathogenicity, attenuation, and immunogenicity of infectious bursal disease virus. Avian Dis. 40:567-571.
6. Muller H, Mundt E, Eterradossi N, Islam MR. 2012. Current status of vaccines against infectious bursal disease. Avian Pathol. 41:133-139.
7. Delmas B, Kibenge FSB, Leong JC, Mundt E, Vakharia VN, Wu JL. 2004. Birnaviridae, p 561-569. In Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA (ed), Virus taxonomy. Eighth report of the International Committee on Taxonomy of Viruses. Academic Press, London, United Kingdom.
8. Muller H, Becht H. 1982. Biosynthesis of virus-specific proteins in cells infected with infectious bursal disease virus and their significance as structural elements for infectious virus and incomplete particles. J. Virol. 44: 384-392.
9. Letzel T, Coulibaly F, Rey FA, Delmas B, Jagt E, van Loon AA, Mundt E. 2007. Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virus. J. Virol. 81:12827-12835.
10. Schnitzler D, Bernstein F, Muller H, Becht H. 1993. The genetic basis for the antigenicity of the VP2 protein of the infectious bursal disease virus. J. Gen. Virol. 74(Part 8):1563-1571.
11. Coulibaly F, Chevalier C, Gutsche I, Pous J, Navaza J, Bressanelli S, Delmas B, Rey FA. 2005. The birnavirus crystal structure reveals structural relationships among icosahedral viruses. Cell 120:761-772.
12. Birghan C, Mundt E, Gorbalenya AE. 2000. A non-canonical Lon proteinase lacking the ATPase domain employs the Ser-Lys catalytic dyad to exercise broad control over the life cycle of a double-stranded RNA virus. EMBO J. 19:114 -123.
13. Lejal N, Da Costa B, Huet JC, Delmas B. 2000. Role of Ser-652 and Lys-692 in the protease activity of infectious bursal disease virus VP4 and identification of its substrate cleavage sites. J. Gen. Virol. 81:983-992.
14. Casanas A, Navarro A, Ferrer-Orta C, Gonzalez D, Rodriguez JF, Verdaguer N. 2008. Structural insights into the multifunctional protein VP3 of birnaviruses. Structure 16:29 -37.
15. Kibenge FS, Dhillon AS, Russell RG. 1988. Biochemistry and immunology of infectious bursal disease virus. J. Gen. Virol. 69(8):1757-1775.
16. Kochan G, Gonzalez D, Rodriguez JF. 2003. Characterization of the RNA-binding activity of VP3, a major structural protein of infectious bursal disease virus. Arch. Virol. 148:723-744.
17. Luque D, Rivas G, Alfonso C, Carrascosa JL, Rodriguez JF, Caston JR. 2009. Infectious bursal disease virus is an icosahedral polyploid dsRNA virus. Proc. Natl. Acad. Sci. U. S. A. 106:2148 -2152.
18. Tacken MG, Peeters BP, Thomas AA, Rottier PJ, Boot HJ. 2002. Infectious bursal disease virus capsid protein VP3 interacts both with VP1, the RNA-dependent RNA polymerase, and with viral double-stranded RNA. J. Virol. 76:11301-11311.
19. Mundt E, Beyer J, Muller H. 1995. Identification of a novel viral protein in infectious bursal disease virus-infected cells. J. Gen. Virol. 76(2): 437-443.
20. Lombardo E, Maraver A, Espinosa I, Fernandez-Arias A, Rodriguez JF. 2000. VP5, the nonstructural polypeptide of infectious bursal disease virus, accumulates within the host plasma membrane and induces cell lysis. Virology 277:345-357.
21. Liu M, Vakharia VN. 2006. Nonstructural protein of infectious bursal disease virus inhibits apoptosis at the early stage of virus infection. J. Virol. 80:3369 -3377.
22. Yao K, Vakharia VN. 2001. Induction of apoptosis in vitro by the 17-kDa nonstructural protein of infectious bursal disease virus: possible role in viral pathogenesis. Virology 285:50 -58.
23. Macreadie IG, Azad AA. 1993. Expression and RNA dependent RNA polymerase activity of birnavirus VP1 protein in bacteria and yeast. Biochem. Mol. Biol. Int. 30:1169 -1178.
24. von Einem UI, Gorbalenya AE, Schirrmeier H, Behrens SE, Letzel T, Mundt E. 2004. VP1 of infectious bursal disease virus is an RNAdependent RNA polymerase. J. Gen. Virol. 85:2221-2229.
25. Garriga D, Navarro A, Querol-Audi J, Abaitua F, Rodriguez JF, Verdaguer N. 2007. Activation mechanism of a noncanonical RNAdependent RNA polymerase. Proc. Natl. Acad. Sci. U. S. A. 104:20540- 20545.
26. Muller H, Nitschke R. 1987. The two segments of the infectious bursal disease virus genome are circularized by a 90,000-Da protein. Virology 159:174 -177.
27. Irigoyen N, Garriga D, Navarro A, Verdaguer N, Rodriguez JF, Caston JR. 2009. Autoproteolytic activity derived from the infectious bursal disease virus capsid protein. J. Biol. Chem. 284:8064-8072.
28. Chevalier C, Lepault J, Da Costa B, Delmas B. 2004. The last C-terminal residue of VP3, glutamic acid 257, controls capsid assembly of infectious bursal disease virus. J. Virol. 78:3296 -3303.
29. Mundt E, Vakharia VN. 1996. Synthetic transcripts of double-stranded Birnavirus genome are infectious. Proc. Natl. Acad. Sci. U. S. A. 93:11131- 11136.
30. Zierenberg K, Raue R, Nieper H, Islam MR, Eterradossi N, Toquin D, Muller H. 2004. Generation of serotype 1/serotype 2 reassortant viruses of the infectious bursal disease virus and their investigation in vitro and in vivo. Virus Res. 105:23-34.
31. Boot HJ, ter Huurne AA, Hoekman AJ, Peeters BP, Gielkens AL. 2000. Rescue of very virulent and mosaic infectious bursal disease virus from cloned cDNA: VP2 is not the sole determinant of the very virulent
32. Lim BL, Cao Y, Yu T, Mo CW. 1999. Adaptation of very virulent infectious bursal disease virus to chicken embryonic fibroblasts by sitedirected mutagenesis of residues 279 and 284 of viral coat protein VP2. J. Virol. 73:2854 -2862.
33. Mundt E. 1999. Tissue culture infectivity of different strains of infectious bursal disease virus is determined by distinct amino acids in VP2. J. Gen. Virol. 80(8):2067-2076.
34. Qi X, Gao H, Gao Y, Qin L, Wang Y, Gao L, Wang X. 2009. Naturally occurring mutations at residues 253 and 284 in VP2 contribute to the cell tropism and virulence of very virulent infectious bursal disease virus. Antiviral Res. 84:225-233.
35. van Loon AA, de Haas N, Zeyda I, Mundt E. 2002. Alteration of amino acids in VP2 of very virulent infectious bursal disease virus results in tissue culture adaptation and attenuation in chickens. J. Gen. Virol. 83:121-129.
36. Raue R, Islam MR, Islam MN, Islam KM, Badhy SC, Das PM, Muller H. 2004. Reversion of molecularly engineered, partially attenuated, very virulent infectious bursal disease virus during infection of commercial chickens. Avian Pathol. 33:181-189.
37. Boot HJ, Hoekman AJ, Gielkens AL. 2005. The enhanced virulence of very virulent infectious bursal disease virus is partly determined by its B-segment. Arch. Virol. 150:137-144.
38. Hon CC, Lam TY, Drummond A, Rambaut A, Lee YF, Yip CW, Zeng F, Lam PY, Ng PT, Leung FC. 2006. Phylogenetic analysis reveals a correlation between the expansion of very virulent infectious bursal disease virus and reassortment of its genome segment B. J. Virol. 80:8503- 8509.
39. Islam MR, Zierenberg K, Muller H. 2001. The genome segment B encoding the RNA-dependent RNA polymerase protein VP1 of very virulent infectious bursal disease virus (IBDV) is phylogenetically distinct from that of all other IBDV strains. Arch. Virol. 146:2481-2492.
40. Jackwood DJ, Sommer-Wagner SE, Crossley BM, Stoute ST, Woolcock PR, Charlton BR. 2011. Identification and pathogenicity of a natural reassortant between a very virulent serotype 1 infectious bursal disease virus (IBDV) and a serotype 2 IBDV. Virology 420:98 -105.
41. Le Nouen C, Rivallan G, Toquin D, Darlu P, Morin Y, Beven V, de Boisseson C, Cazaban C, Comte S, Gardin Y, Eterradossi N. 2006. Very virulent infectious bursal disease virus: reduced pathogenicity in a rare natural segment-B-reassorted isolate. J. Gen. Virol. 87:209 -216.
42. Le Nouën C, Toquin D, Muller H, Raue R, Kean KM, Langlois P, Cherbonnel M, Eterradossi N. 2012. Different domains of the RNA polymerase of infectious bursal disease virus contribute to virulence. PLoS One 7:e28064. doi:10.1371/journal.pone.0028064.
43. Eterradossi N, Arnauld C, Toquin D, Rivallan G. 1998. Critical amino acid changes in VP2 variable domain are associated with typical and atypical antigenicity in very virulent infectious bursal disease viruses. Arch. Virol. 143:1627-1636.
44. Eterradossi N, Toquin D, Rivallan G, Guittet M. 1997. Modified activity of a VP2-located neutralizing epitope on various vaccine, pathogenic and hypervirulent strains of infectious bursal disease virus. Arch. Virol. 142: 255-270.
45. Pan J, Vakharia VN, Tao YJ. 2007. The structure of a birnavirus polymerase reveals a distinct active site topology. Proc. Natl. Acad. Sci. U. S. A. 104:7385-7390.
46. Eterradossi N, Rivallan G, Toquin D, Guittet M. 1997. Limited antigenic variation among recent infectious bursal disease virus isolates from France. Arch. Virol. 142:2079 -2087.
47. Bygrave AC, Faragher JT. 1970. Mortality associated with Gumboro disease. Vet. Rec. 86:758 -759.
48. Islam MR, Zierenberg K, Eterradossi N, Toquin D, Rivallan G, Muller H. 2001. Molecular and antigenic characterization of Bangladeshi isolates of infectious bursal disease virus demonstrate their similarities with recent European, Asian and African very virulent strains. J. Vet. Med. B Infect. Dis. Vet. Public Health 48:211-221.
49. Eterradossi N, Picault JP, Drouin P, Guittet M, L'Hospitalier R, Bennejean G. 1992. Pathogenicity and preliminary antigenic characterization of six infectious bursal disease virus strains isolated in France from acute outbreaks. Zentralbl. Veterinarmed. B 39:683- 691.
50. Reed LJ, Muench H. 1938. A simple method of estimation of fifty per cent end-points. Am. J. Hyg. 27:493- 497.
51. Mundt E, Muller H. 1995. Complete nucleotide sequences of 5=- and 3=-noncoding regions of both genome segments of different strains of infectious bursal disease virus. Virology 209:10 -18.
52. Eterradossi N, Gauthier C, Reda I, Comte S, Rivallan G, Toquin D, de Boisseson C, Lamande J, Jestin V, Morin Y, Cazaban C, Borne PM. 2004. Extensive antigenic changes in an atypical isolate of very virulent infectious bursal disease virus and experimental clinical control of this virus with an antigenically classical live vaccine. Avian Pathol. 33:423- 431.
53. Skeeles JK, Luckert PD, Fletcher OJ, Leonard DJ. 1979. Immunization studies with a cell culture adapted infectious bursal disease virus. Avian Dis. 23:456-465.
54. Escaffre O, Queguiner M, Eterradossi N. 2010. Development and validation of four real-time quantitative RT-PCRs specific for the positive or negative strands of a bisegmented dsRNA viral genome. J. Virol. Methods 170:1- 8.
55. Dundas J, Ouyang Z, Tseng J, Binkowski A, Turpaz Y, Liang J. 2006. CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res. 34:W116-W118.
56. Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, Leslie AG, McCoy A, McNicholas SJ, Murshudov GN, Pannu NS, Potterton EA, Powell HR, Read RJ, Vagin A, Wilson KS. 2011. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67:235-242.
57. Humphrey W, Dalke A, Schulten K. 1996. VMD: visual molecular dynamics. J. Mol. Graph. 14:33-38, 27-28.
58. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kale L, Schulten K. 2005. Scalable molecular dynamics with NAMD. J. Comput. Chem. 26:1781-1802.
59. Brooks BR, Brooks CL, III, Mackerell AD, Jr, Nilsson L, Petrella RJ, Roux B, Won Y, Archontis G, Bartels C, Boresch S, Caflisch A, Caves L, Cui Q, Dinner AR, Feig M, Fischer S, Gao J, Hodoscek M, Im W, Kuczera K, Lazaridis T, Ma J, Ovchinnikov V, Paci E, Pastor RW, Post CB, Pu JZ, Schaefer M, Tidor B, Venable RM, Woodcock HL, Wu X, Yang W, York DM, Karplus M. 2009. CHARMM: the biomolecular simulation program. J. Comput. Chem. 30:1545-1614.
60. Wallace AC, Laskowski RA, Thornton JM. 1995. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8:127-134.
61. Brown MD, Skinner MA. 1996. Coding sequences of both genome segments of a European 'very virulent' infectious bursal disease virus. Virus Res. 40:1-15.
62. Eterradossi N, Arnauld C, Tekaia F, Toquin D, Le Coq H, RivallanG, Guittet M, Domenech J, van den Berg TP, Skinner MA. 1999. Antigenic and genetic relationships between European very virulent infectious bursal disease viruses and an early West African isolate. Avian Pathol. 28:36 - 46.
63. Delgui L, Ona A, Gutierrez S, Luque D, Navarro A, Caston JR, Rodriguez JF. 2009. The capsid protein of infectious bursal disease virus contains a functional α4 β1 integrin ligand motif. Virology 386:360 -372.
64. Wei Y, Li J, Zheng J, Xu H, Li L, Yu L. 2006. Genetic reassortment of infectious bursal disease virus in nature. Biochem. Biophys. Res. Commun. 350:277-287.
65. Wei Y, Yu X, Zheng J, Chu W, Xu H, Yu L. 2008. Reassortant infectious bursal disease virus isolated in China. Virus Res. 131:279 -282.
66. Lazarus D, Pasmanik-Chor M, Gutter B, Gallili G, Barbakov M, Krispel S, Pitcovski J. 2008. Attenuation of very virulent infectious bursal disease virus and comparison of full sequences of virulent and attenuated strains. Avian Pathol. 37:151-159.
67. Graham SC, Sarin LP, Bahar MW, Myers RA, Stuart DI, Bamford DH, Grimes JM. 2011. The N-terminus of the RNA polymerase from infectious pancreatic necrosis virus is the determinant of genome attachment. PLoS Pathog. 7:e1002085. doi:10.1371/journal.ppat.1002085.
68. Rautenschlein S, Yeh HY, Sharma JM. 2003. Comparative immunopathogenesis of mild, intermediate, and virulent strains of classic infectious bursal disease virus. Avian Dis. 47:66 -78.
69. Tanimura N, Tsukamoto K, Nakamura K, Narita M, Maeda M. 1995. Association between pathogenicity of infectious bursal disease virus and viral antigen distribution detected by immunohistochemistry. Avian Dis. 39:9 -20.
70. Tsukamoto K, Tanimura N, Mase M, Imai K. 1995. Comparison of virus replication efficiency in lymphoid tissues among three infectious bursal disease virus strains. Avian Dis. 39:844-852.
71. Williams AE, Davison TF. 2005. Enhanced immunopathology induced by very virulent infectious bursal disease virus. Avian Pathol. 34:4 -14. 72. Pan J, Lin L, Tao YJ. 2009. Self-guanylylation of birnavirus VP1 does not require an intact polymerase activity site. Virology 395:87-96.
72. Pan J, Lin L, Tao YJ. 2009. Self-guanylylation of birnavirus VP1 does not require an intact polymerase activity site. Virology 395:87-96.